APA (7th ed.) Citation

Larrinaga, G., Valdivia, A., Arrieta-Aguirre, I., Solano-Iturri, J. D., Ugalde-Olano, A., Loizaga-Iriarte, A., . . . López, J. I. (2024). The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy. International Journal of Molecular Sciences, 25(3), 1499. https://doi.org/10.3390/ijms25031499

Chicago Style (17th ed.) Citation

Larrinaga, Gorka, et al. "The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy." International Journal of Molecular Sciences 25, no. 3 (2024): 1499. https://doi.org/10.3390/ijms25031499.

MLA (9th ed.) Citation

Larrinaga, Gorka, et al. "The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy." International Journal of Molecular Sciences, vol. 25, no. 3, 2024, p. 1499, https://doi.org/10.3390/ijms25031499.